Not checkedNot checked for notices yet.
Diagnostic evidence cooperatives: bridging the valley of death in diagnostics development
Ann Van den Bruel, Gail Hayward
Diagnostic and Prognostic Research · 2018
doi:10.1186/s41512-018-0030-9 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Background Diagnostic tests’ impact on patient outcomes and health processes is potentially large, and proper evaluations before widespread adoption are warranted. Such evaluations are challenged by the fact that tests can have multiple purposes, in different clinical pathways, with different roles. Body The National Institute for Health Research (NIHR) established four Diagnostic Evidence Cooperatives (DEC) in 2013, across England. The aim of these DECs was to facilitate the development and evaluation of clinically relevant in vitro diagnostics, by offering methodological expertise and access to real-life settings for evaluations in patients. In this commentary, we discuss our experience over the past 4 years. Conclusion The interaction of industry, researchers, and clinicians has proven to be very worthwhile.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.